Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).
Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).
A cross-sectional study among transgender, nonbinary, and cisgender youths in the U.S. looked at associations between social media use and indicators of mental health.
LONDON, July 31, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online
Whilst growth in the overall digital pathology AI market is set to scale quickly, cannibalization and consolidation are expected to create headwinds for individual AI
Does anyone still remember the initial phase of the Corona pandemic in 2020? When shops, restaurants, cinemas, and theatres remained closed. When meetings with friends
A new study from Tulane University has identified a new treatment for a chronic immune system disease that can prevent children from eating.
Even in adults without hypertension, blood pressure readings may climb more steeply over the years as the number of daily alcoholic drinks rise, according to
Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.
A global study co-led by researchers from The University of Queensland and Harvard Medical School has found one in two people will develop a mental